Cervical Cancer

GSK Awaits FDA Decision On Cervarix HPV Vaccine, Hopes To Compete With Merck's Gardasil
FDA is expected to make a decision in the next several months over whether to approve GlaxoSmithKline's human papillomavirus vaccine Cervarix for the U.S. market, the AP/Philadelphia Inquirer reports.